|
 |
SpirivaThis page contains recent news articles, when available, and an overview of Spiriva but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Patients taking tiotropium bromide (Spiriva) for chronic obstructive pulmonary disease (COPD) appear to be at decreased risk for death and cardiovascular ... MedPage Today Pfizer, Boehringer's Spiriva gets new FDA approval - Dec 18, 2009 Boehringer Ingelheim Pharmaceuticals Inc. and Pfizer Inc. said Thursday the Food and Drug Administration approved Spiriva HandiHaler as a treatment for ... BusinessWeek Spiriva has Closed the Gap in Patient Share Between Itself and Advair for the ... - Dec 22, 2009 Although Advair's patient share in the first line is still greater than Spiriva's, Spiriva has surpassed Advair in the second line and will continue to ... PR Newswire (press release) Spiriva HandiHaler Approved for the Reduction of COPD Exacerbations - Dec 22, 2009 How many of you use Spiriva HandiHaler for long-term maintenance treatment of your COPD? Now, there's is one more reason to continue to do so. ... About - News & Issues (blog) Boehringer's US Biz to Mindshare - Dec 18, 2009 The client markets brands such as Flomax and Spiriva. The switch will take effect next year. Boehringer spent about $225 million in measured media for its ... Adweek Ads inflating prescription drug prices - Dec 22, 2009 In November, 2007, I reported in a Chapel Hill News column that a prescription for Spiriva, which was supposed to aid my breathing, instead took my breath ... Chapel Hill News FDA panel: Gilead Sciences drug to treat deadly lung infection appears safe ... - Dec 10, 2009 November 19th, 2009 more images more images FDA panel backs safety, benefits of Spiriva WASHINGTON — Federal health experts on Thursday brushed off ... Gaea Times (blog) FDA Approves SPIRIVA HandiHaler For The Reduction Of COPD - Dec 21, 2009 Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer Inc announced recently that the US Food and Drug Administration (FDA) has approved SPIRIVA HandiHaler ... BioResearch Online (press release) Pharma sought safe havens for DTC in '09 - Dec 31, 2009 The company's other DTC advertising—for neurology treatment Lyrica, stop-smoking pill Chantix, as well as COPD treatment Spiriva (with Boehringer ... Medical Marketing and Media Anti-smoking drugs in health basket - Dec 23, 2009 Humira, Enbrel, Remicade and Amevive for dermatology; Abilify for psychiatry; Spiriva for lung disease; and Combigan for eye disease. ... Jerusalem Post US stock market opening report (December 18, 2009, Friday) - Dec 18, 2009 Food and Drug Administration has approved Spiriva HandiHaler for the reduction of exacerbations in patients with chronic obstructive pulmonary disease. ... Stock Markets Review Positive Earnings May Support a Rebound - Dec 18, 2009 Pfizer (PFE) could be in focus after it announced that the FDA has approved SPIRIVA handihaler, which is used for reduction of exacerbations in patients ... RTT News FDAæ ¸å‡†Tiotropium用於減少COPD惡化 - Dec 25, 2009 ...ã€?24drs.com】December 18, 2009 — 美國食å“?藥物管ç?†å±€(FDA)æ ¸å‡†å?¸å…¥åž‹é•·æ•ˆæŠ—膽鹼製劑tiotropium bromide (商å“?å??Spiriva HandiHaler，Boehringer Ingelheim ... 臺灣新浪網 í??ì§ˆí™˜ìš”ë²•ì œ '스피리바' ë‚ ê°œ 달았다 - Dec 19, 2009 ...주민우 기ìž? [헬스코리아뉴스] FDAê°€ ë² ë§?ê±° ì?¸ê²”하임과 í™”ì?´ìž?ì?˜ 만성í??쇄성 í??질환ì?˜ ìœ ì§€ìš”ë²•ì œ '스피리바(Spiriva Handihaler/tiotropium bromide inhalation ... 헬스코리아뉴스 ë² ë§?거잉겔하임 í??질환 치료 í?¡ìž…약, ì ?ì?‘ì¦? 추가 - Dec 21, 2009 ...김윤ì˜? 기ìž? FDA는 ë² ë§?거잉겔하임 ë°? í™”ì?´ìž?ê°€ ì‹ ì²í•œ 스피리바 핸디헤ì?¼ëŸ¬ í?¡ìž… 분ë§?ì œ(Spiriva HandiHaler: tiopropium bromide inhalation powder)ì—? 대go 만성 ... 메디포뉴스 COPD 치료 3대 브랜드 'ì?¼ìž¥ì?¼ë‹¨' - Dec 27, 2009 ...만성í??쇄성í??질환(COPD) 치료 3대 브랜드ì?¸ 'ì• ë“œë² ì–´'(Advair, fluticasone/ salmeterol), '스피리바'(Spiriva, tiotropium), '심비코트'(Symbicort, ... 디지틀보사 Boehringer Ingelheim: Ein Stern fällt vom Unternehmenshimmel - Dec 18, 2009 Und Spiriva – die erste Arznei gegen Raucherlunge und Boehringers wichtigster Umsatzbringer – wird von einer Neuentwicklung des Wettbewerbers Novartis ... ZEIT ONLINE Brand Name: Spiriva - Nov 11, 2009 Spiriva is used to make breathing easier for people with conditions such as chronic obstructive pulmonary disease (COPD), bronchitis and emphysema. ... Pattaya Daily News CHEST: No Sex Difference Found in COPD Treatment - Nov 4, 2009 SAN DIEGO -- Men and women with chronic obstructive pulmonary disorder (COPD) derive comparable benefits from treatment with tiotropium (Spiriva), ... MedPage Today Pfizer earnings up 26% despite lower sales of many drugs - Oct 21, 2009 Alliance revenues, notably from Eisai's Alzheimer's disease treatment Aricept (donepezil) and Boehringer Ingelheim's Spiriva (tiotropium) for chronic ... Pharma Times CHEST: COPD Treatment Determines Risk of Hospitalization - Nov 6, 2009 Monotherapy with tiotropium (Spiriva) resulted in the lowest risk of COPD-related hospitalization, Emily Durden, PhD, of Thomson Reuters in Austin, Tex., ... MedPage Today GSK begins phase III COPD trials - Oct 28, 2009 Seretide's rivals, AstraZeneca's Symbicort and Boehringer Ingelheim's Spiriva, had combined sales of more than £200 million. And the British Lung Foundation ... Pharmafocus FDA wants more data on Novartis' COPD drug indacaterol - Oct 20, 2009 ...more late-stage data on indacaterol which the Swiss major says show significant benefits over Boehringer Ingelheim/Pfizer's Spiriva (tiotropium). ... Pharma Times BEN column — Everybody helps CRHS Booster Golf; Warren Robinson questions ... - Nov 2, 2009 ...“Cough is almost non-existent, and as of yesterday, I'm not using my inhaler or Spiriva HandiHaler. Amazing difference in me and this is only a short time ... NJ.com REG-Pfizer Inc Pfizer Reports Third-Quarter 2009 Results - Oct 20, 2009 1872 1622 15 1133 934 21 739 688 7 Spiriva, Rebif and Exforge) ANIMAL HEALTH 1863 2042 (9 ) 749 812 (8 ) 1114 1230 (9 ) OTHER *** 767 975 (21 ) 213 325 ... Reuters 2009-10-14Den nya lÃ¥ngverkande bronkvidgaren Onbrez gav bättre effekt pÃ¥ flera ... - Oct 21, 2009 Enligt Läkemedelsverkets senaste behandlingsrekommendation för kroniskt obstruktiv lungsjukdom, KOL, är det lÃ¥ngverkande antikolinergikumet Spiriva ... Dagens Medicin Study links lung drug Spiriva to heart death risk - Sep 23, 2008 By Will Dunham. WASHINGTON, Sept 23 (Reuters) - The blockbuster inhaled lung medication Spiriva, marketed by Pfizer Inc (PFE.N) and Boehringer Ingelheim, ... Reuters Pfizer's Spiriva may raise risk of stroke-US FDA - Mar 18, 2008 By Susan Heavey. WASHINGTON, March 18 (Reuters) - The lung drug Spiriva, marketed by Pfizer Inc (PFE.N) and Boehringer Ingelheim Pharmaceutical Inc, ... Reuters Spiriva Safe, Effective for COPD Patients - Oct 5, 2008 By Steven Reinberg. SUNDAY, Oct. 5 (HealthDay News) -- For patients suffering from chronic obstructive pulmonary disease (COPD), tiotropium (Spiriva) ... BusinessWeek Advair vs. Spiriva: Fewer COPD Deaths - Dec 28, 2007 By Daniel J. DeNoon. Dec. 28, 2007 -- Severe COPD patients treated with Advair or Spiriva had the same rate of COPD attacks, but Advair patients were only ... WebMD SPIRIVA(R) Significantly Improves Lung Function in Patients With Mild... - Sep 6, 2006 Patients with mild(x) chronic obstructive pulmonary disease (COPD) treated with SPIRIVA(R) (tiotropium) experienced significantly improved lung function ... Newswit.com Boehringer says Spiriva, formoterol cause 'superior' improvement in... - Sep 19, 2005 FRANKFURT (AFX) - German pharmaceutical group Boehringer Ingelheim GmbH said a study showed its respiratory treatment Spiriva to induce 'superior lung ... Forbes Study links lung drug Spiriva to heart death risk - Sep 24, 2008 By Will Dunham. WASHINGTON (Reuters) - The blockbuster inhaled lung medication Spiriva, marketed by Pfizer Inc (PFE.N: Quote, Profile, Research) and ... Reuters UK RPT-Spiriva shows little aid to long-term lung function - Oct 6, 2008 By Gene Emery. BOSTON, Oct 6 (Reuters) - Spiriva, marketed by Pfizer (PFE.N) and Boehringer Ingelheim, offered no advantage over an inhaled placebo for ... Reuters Broker sees Glaxo's Advair losing sales to Spiriva - Sep 29, 2008 By Ben Hirschler. LONDON (Reuters) - GlaxoSmithKline's (GSK.L) top-selling respiratory drug Advair is set to lose business to Spiriva, marketed by Pfizer ... Reuters Glaxo's Advair doesn't cut smokers lung symptoms, study says - Mar 16, 2007 The patients took either a combination of Advair with Spiriva, Spiriva and placebo or Spiriva and Serevent, an older asthma drug made by GlaxoSmithKline. ... MarketWatch Pfizer's Spiriva may raise risk of stroke-US FDA - Mar 19, 2008 By Susan Heavey. WASHINGTON, March 18 (Reuters) - The lung drug Spiriva, marketed by Pfizer Inc (PFE.N: Quote, Profile, Research) and Boehringer Ingelheim ... Reuters India Ohio subsidiary of German drugmaker completes expansion. - Apr 29, 2005 Roxane, the North American manufacturer for Germany-based Boehringer Ingelheim, recently began making Spiriva HandiHaler at its Wilson Road plant for export ... Free with registration - Columbus Dispatch - AccessMyLibrary.com Spiriva problems may boost Glaxo's Advair drug - Mar 19, 2008 LONDON, March 19 (Reuters) - Safety questions over the lung drug Spiriva, marketed by Pfizer Inc (PFE.N: Quote, Profile, Research) and Germany's Boehringer ... Reuters India … - strong growth and profits once again - Spiriva® the first... - Apr 4, 2006 The medication Spiriva®, for chronic obstructive pulmonary disease (COPD), ... Spiriva® grew by 80% against the previous year and has become the ... webwire.com Boehringer Ingelheim says FY net gains 15.5 pct on prescription … - Mar 27, 2007 15.5 pct to 1.722 bln eur as the company sold more prescription medicines such as respiratory treatment Spiriva and blood pressure treatment Micardis. ... Forbes Broker sees Glaxo's Advair losing sales to Spiriva - Sep 26, 2008 By Ben Hirschler. LONDON, Sept 26 (Reuters) - GlaxoSmithKline's (GSK.L) top-selling respiratory drug Advair is set to lose business to Spiriva, ... Reuters Spiriva(R) Consistently Reduces Exacerbations And Associated … - May 29, 2006 Patients with chronic obstructive pulmonary disease (COPD) treated with Spiriva(R) (tiotropium) for 6-12 months experienced significantly fewer ... Medical News Today - Medical News Today (press release) Spiriva may slow decline in FEV, a measure of lung function in... - Apr 7, 2005 FEV1 is defined as the volume of air that can be forcefully exhaled in one second (FEV1 = Forced expiratory volume in one second). ... Medical News Today - Medical News Today (press release) Study: Inhaler Drugs Tied to Heart Problems, Deaths - Sep 24, 2008 The drugs are tiotropium, sold as Spiriva Handihaler by Boehringer ... Spiriva, approved in 2004, and the decade-old Atrovent are used once or more daily to ... FOXNews Spiriva Improved Lung Function in COPD Patients of African Descent. - May 21, 2006 SAN DIEGO, May 21 /PRNewswire/ -- New study results show that treatment with Spiriva(R) HandiHaler(R) (tiotropium bromide inhalation powder) significantly ... Free with registration - PR Newswire - AccessMyLibrary.com Verispan Reports: Spiriva Becoming a Preferred Drug in Managed Care - Sep 14, 2005 Spiriva, Boehringer Ingelheim and Pfizer's treatment for chronic obstructive pulmonary disease, has gained formulary status at 81% of managed care ... RedOrbit Spiriva HandiHaler.(Drug overview) - Jan 22, 2007 Spiriva is used for the long-term, once-a-day treatment of bronchial spasms (wheezing) associated with chronic obstructive pulmonary disease, ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com Press Release: SPIRIVA(R) Significantly Improves Lung Function in … - Sep 5, 2006 SPIRIVA(R) Significantly Improves Lung Function in Patients With Mild COPD. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research Verispan Reports: Spiriva Gaining Acceptance in Managed Care. - Mar 4, 2005 YARDLEY, Pa. -- Less than 10 months after its May 2004 launch, Spiriva, Boehringer Ingelheim and Pfizer's new treatment for patients suffering from chronic ... Free with registration - Business Wire - AccessMyLibrary.com FDA Rethinks Spiriva Stroke Warning - Oct 9, 2008 By Daniel J. DeNoon. Oct. 9, 2008 – The FDA is reconsidering its recent warning that the lung disease drug Spiriva might raise stroke risk. ... WebMD Spiriva Respimat OKed for COPD in Europe.(chronic obstructive … - Jul 30, 2007 German drug major Boehringer Ingelheim and world pharmaceutical giant Pfizer have completed the approval process for authorization to market their ... Free with registration - Pharma Marketletter - AccessMyLibrary.com … -Analysis of Clinical Studies Shows: SPIRIVA(R) Consistently... - May 23, 2006 A Meta-Analysis of Clinical Studies Shows: SPIRIVA(R) Consistently Reduces Exacerbations and Associated Hospitalisations in Patients With COPD. from PR ... Pay-Per-View - PR Newswire Europe - HighBeam Research Spiriva® (tiotropium) improves quality of life in patients with COPD,... - May 28, 2005 COPD is a progressive respiratory disease that causes significant deterioration of lung function and chronic breathlessness, which is a major cause of ... Medical News Today - Medical News Today (press release) Boehringer-Ingelheim: Respimat Aims to Protect Spiriva's Success - Sep 8, 2006 The reformulation of the best-selling asthma/COPD drug Spiriva in the ... Phase III trials for Spiriva in this device were successfully completed and BI is ... RedOrbit Data show no stroke risk with Pfizer lung drug-FDA - Oct 7, 2008 Spiriva HandiHaler aims to treat chronic obstructive pulmonary disease, or COPD, and is co-marketed by Pfizer (nyse: PFE - news - people ) and Boehringer ... Forbes New SPIRIVA Respimat Approved in Europe - Aug 9, 2007 Boehringer Ingelheim and Pfizer announced successful completion of the approval process for SPIRIVA® Respimat® to be sold in 25 countries of the European ... news Stories Spiriva will Attain Sales of Approximately $2.8 Billion for Treatment... - May 3, 2005 WALTHAM, Mass., May 3 /PRNewswire/ -- Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and health ... $4.95 - PR Newswire - ECNext Boehringer sees alternative to Spiriva inhaler device - Sep 11, 2006 By Gregory Roumeliotis, 11-Sep-2006. The world's most prescribed product for chronic obstructive pulmonary disease (COPD) could soon be formulated with a ... In-PharmaTechnologist.com Boehringer to Buy Actimis in Structured Buyout for $515 Million - Jun 17, 2008 Spiriva had 1.8 billion euros ($2.8 billion) in sales last year. AP768 is in the first of three sets of human trials usually needed for regulatory approval. ... Bloomberg Spiriva - Tiotropium Bromide - Medical Drug - Mar 12, 2007 There are no adequate studies to support the use of Spiriva in pregnant and breastfeeding women (Category B1). It should only be considered if the potential ... Virtual Medical Centre - The Virtual Medical Centre Forest Labs hits 7-year low on trial results - Sep 3, 2008 Spiriva is an inhaled drug marketed by Pfizer and Boehringer Ingelheim as a treatment for chronic obstructive pulmonary disease. ... Boston Globe Boehringer Ingelheim H1 EBIT dips 10 pct on currency effects,... - Aug 7, 2008 Sales from Boehringer's best-selling Spiriva inhalant against chronic obstructive pulmonary disease (COPD) rose a currency-adjusted 23.8 percent to 976 ... Forbes Press Release: Spiriva will Attain Sales of Approximately $2.8... - May 3, 2005 Spiriva will Attain Sales of Approximately $2.8 Billion for Treatment of Chronic Obstructive Pulmonary Disease (COPD) in 2013. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research FDA issues Spiriva and Foradil advisory - Mar 3, 2008 WASHINGTON, March 3 (UPI) -- The US Food and Drug Administration has issued a public health advisory concerning the correct use of Spiriva and Foradil ... United Press International … Cost, Boehringer Ingelheim/Pfizer's Spiriva Consistently Leads... - Dec 12, 2006 ..."However, Spiriva does have its advantages as many specialists and primary care physicians rank Spiriva's greater improvement of lung function as a primary ... $4.95 - PR Newswire - ECNext … -Line Use of Boehringer Ingelheim/Pfizer's Spiriva in Chronic... - Dec 17, 2007 ...finds that first- and second-line use of Boehringer Ingelheim/Pfizer's Spiriva in the treatment of chronic obstructive pulmonary disease (COPD) will ... $4.95 - PR Newswire - ECNext Drug Firms' Touch Light at Disease Talk - May 6, 2005 If the makers of Spiriva were hoping for heavy- handed endorsements at the luncheon, they were disappointed. Of the three speakers, which included an ... RedOrbit Novartis says NVA237 promising in mid-stage trial - Oct 7, 2008 The drug showed similar efficacy and duration of action to tiotropium -- the generic name for Spiriva, marketed by Pfizer Inc (PFE. ... Reuters Sales of Spiriva Could Reach Y20 Bil. in the Near Future: NBI - Dec 4, 2006 Nippon Boehringer Ingelheim (NBI) and Pfizer Japan commemorated the approval of the COPD treatment Spiriva (tiotropium) two years ago at an event held in ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones GSK claims Seretide superior to Spiriva - Jan 3, 2008 A new head-to-head study sponsored by GSK suggests its drug Seretide reduced the risk of dying compared to rival treatment Spiriva. ... Pharmafocus Interim Results of UPLIFT Trial Show Improvement in Lung Function... - Sep 28, 2005 The study is being funded by Boehringer Ingelheim, which manufactures Spiriva. [Presentation title: Acute Bronchodilator Responsiveness in a Global ... DG News COPD Landmark Trial UPLIFT Proves Tiotropium Sustains Lung Function … - Oct 6, 2008 Results of the UPLIFT trial, presented today at the European Respiratory Society (ERS) Annual Congress, demonstrated that tiotropium (SPIRIVA) administered ... ANTARA Press Release: Spiriva Improved Lung Function in COPD Patients of … - May 21, 2006 Spiriva Improved Lung Function in COPD Patients of African Descent. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Atrovent(R) HFA Now Available For COPD Patients - May 23, 2005 In June of 2004, the company launched Spiriva(R) HandiHaler(R) (tiotropium ... SPIRIVA is available in a propellant-free dry-powder in a capsule formulation ... RedOrbit … Cost, Boehringer Ingelheim/Pfizer's Spiriva Consistently Leads... - Dec 12, 2006 Despite Higher Cost, Boehringer Ingelheim/Pfizer's Spiriva Consistently Leads Both Serevent and Foradil by a Wide Margin in First-, Second-, and Third-Line ... Pay-Per-View - PR Newswire - HighBeam Research CAN I TAKE ADVAIR WITH SINGULAR & SPIRIVA - Jun 26, 2008 Are you an asthma suffer? Manage your asthma or COPD with great ideas from people like you.Start here. i HAVE ASTHMA AND HAVE BEEN ON ADVIR & SINGULAIR FOR ... HealthCentral.com Spiriva and Micardis boost Boehringer's 2007 sales 8.8%, as profit... - Apr 14, 2008 Spiriva and Micardis boost Boehringer's 2007 sales 8.8%, as profit jumps 4.8% to $2.8M. German drug major Boehringer Ingelheim has outpaced market growth ... $9.94 - Pharma Marketletter - Alacra Store BI/Pfizer's Spiriva improves quality of life in COPD.(Brief Article) - May 30, 2005 Germany's Boehringer Ingelheim and US pharmaceutical giant Pfizer say that patients with chronic obstructive pulmonary disease, which is currently the ... $4.95 - Pharma Marketletter - ECNext BI/Pfizer's Spiriva improves lung function in mild COPD. - Sep 11, 2006 BI/Pfizer's Spiriva improves lung function in mild COPD. German drug major Boehringer Ingelheim and world pharmaceutical giant Pfizer say that patients with ... $9.94 - Pharma Marketletter - Alacra Store COPD and Spiriva: How to Maximize its Effectiveness - Jul 7, 2008 Are you an asthma sufferer? Manage your asthma or COPD with great ideas from people like you.Start here. I'm sure most of you with COPD (Chronic Obstructive ... HealthCentral.com New Spiriva Study Touts Lung Drug Safety, Protects Heart - Sep 25, 2008 Washington (ChattahBox) - Data from a new clinical trial has been released early by Pfizer and Boerhinger Ingelheim showing that their lung drug inhaler ... ChattahBox Singulair vs. Advair and Spiriva - May 16, 2008 Are you an asthma suffer? Manage your asthma or COPD with great ideas from people like you.Start here. Now I use Advair 250/50 and Spiriva, I would love to ... HealthCentral.com FDA Issues Spiriva and Foradil Advisory - Mar 4, 2008 Washington -- The US Food and Drug Administration has issued a public health advisory concerning the correct use of Spiriva and Foradil capsules. ... Money Times - The Money Times Glaxo's Seretide improves lung-disease patient survival: study - Dec 27, 2007 Seretide and Spiriva are the most commonly used drugs to treat this condition. ... In addition, patients taking Spiriva were 29% more likely to withdraw ... MarketWatch REHAB CAN HELP WITH COPD - Mar 19, 2008 Two examples are Spiriva and Atrovent. Inhaled cortisone sprays ease airway irritation and decrease mucus production. Do you take advantage of pulmonary ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver Spiriva use for chronic obstructive pulmonary disease tied to... - Apr 15, 2008 Spiriva use for chronic obstructive pulmonary disease tied to stroke.(NEWS FROM THE FDA) ... find Family Practice News articles. Use of Pfizer/Boehringer ... Pay-Per-View - Family Practice News - HighBeam Research Press Release: Established Safety Profile of Spiriva Confirmed by 30 ... - Sep 23, 2008 Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial UPLIFT. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research … UPLIFT Study Reaffirms the Safety of Spiriva (tiotropium) in... - Sep 24, 2008 Landmark UPLIFT Study Reaffirms the Safety of Spiriva (tiotropium) in Patients With Chronic Obstructive Pulmonary Disease.(Clinical report) from PR Newswire ... Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: Advair Is Positioned Ahead of Spiriva In First and... - Nov 12, 2008 Advair Is Positioned Ahead of Spiriva In First and Second Lines of Therapy for the Treatment of Chronic Obstructive Pulmonary Disease. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Awareness campaign close-up: Lung group plans global COPD day - Nov 10, 2005 The activity is supported by Boehringer Ingelheim/ Pfizer (the drugs firms behind COPD treatment Spiriva), diagnostic product firm Vitalograph and the ... PRWeek UK BI/Pfizer's Spiriva improves lung function in mild COPD.(chronic … - Sep 11, 2006 German drug major Boehringer Ingelheim and world pharmaceutical giant Pfizer say that patients with mild chronic obstructive pulmonary disease treated with ... $4.95 - Pharma Marketletter - ECNext Novel soft mist COPD inhaler set for EU - Jul 26, 2007 The once-daily Spiriva Respimat product will contain 2.5 micrograms of drug ... Each Spiriva Respimat device will provide enough treatment for one month. ... In-PharmaTechnologist.com … : Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) … - Oct 5, 2008 Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research … Release: Analyze How the Asthma and COPD Therapy Spiriva Will Act... - Jul 9, 2008 Analyze How the Asthma and COPD Therapy Spiriva Will Act as the Key Driver of Boehringer Ingelheims Commercial Performance out to 2012. from M2 Presswire. Pay-Per-View - M2 Presswire - HighBeam Research Continued strong growth at Boehringer Ingelheim - Aug 10, 2006 Spiriva® achieved net sales of EUR 640 million in the first half-year (+55 % against the previous year). Net sales of Micardis®, a medication for reducing ... ThePigSite.com Atlanta health, diet and fitness news | ajc.com - Mar 19, 2008 In 25 of the clinical studies, patients were treated with Spiriva HandiHaler, which is a once-daily, long-term maintenance medicine. In the other four, ... Atlanta Journal Constitution Sosei/Vectura drug may act faster than Spiriva. - Oct 13, 2008 Sosei/Vectura drug may act faster than Spiriva. Japanese biopharmaceutical company Sosei and its UK-based partner Vectura presented data from two Phase II ... $9.94 - Pharma Marketletter - Alacra Store Spiriva HandiHaler. - Apr 1, 2008 Spiriva HandiHaler. Boehringer Ingelheim has informed FDA of a potentially increased risk of stroke among patients treated with tiotropium (Spiriva ... $9.94 - Formulary - Alacra Store Spiriva improves lung function in patients with mild COPD: NBI,... - Sep 25, 2006 ...pulmonary disease (COPD) treated with Spiriva (triotropium) experienced significantly improved lung function compared to those receiving a placebo. ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones Tiotropium Significantly Improves Lung Function in Patients With Mild... - Sep 12, 2006 Spiriva® positively impacts the clinical course of COPD, helping to change ... Spiriva® works through targeting of a dominant reversible mechanism of COPD ... DG News --Analysis of future high-potential launches and the R&D pipelines of... - Mar 9, 2006 ...--How have recently launched medicines Symbicort and Spiriva performed? --How is the epidemiology of asthma and COPD and the way in which these diseases are ... Free with registration - Business Wire - AccessMyLibrary.com Media Release: Pfizer Inc - Sep 18, 2005 Spiriva(R) works through targeting of a dominant reversible mechanism of COPD ... Spiriva(R) helps COPD patients breathe easier by opening narrowed airways ... Pay-Per-View - AAP MediaNet Press Releases - Factiva, from Dow Jones Article: The FDA ruled.(Update) - Medical Marketing & Media |... - Jul 1, 2006 Spiriva Handihaler (tiotropium bromide inhalation powder, Boehringer Ingelheim) An inhaled ... Article: FDA Approves Spiriva HandiHaler for the Treatment . ... Pay-Per-View - Medical Marketing & Media - HighBeam Research |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
